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Abstract The interaction of DNA topoisomerase I (topo I) with 
a set of single- and double-stranded oligonucleotides containing 
5-27 mononucleotides was investigated. All single- and double- 
stranded oligonucleotides were found to inhibit competitively the 
supercoiled DNA relaxation reaction catalyzed by topo I. The 
enzyme affinity for specific sequence pentanucleotides of the scis- 
sue (GACTT, Ki = 2 /zM) and non-cleaved chain (AAGTC, 
Ki = II0 pM) is about 2-4 orders of magnitude higher than that 
for non-specific oligonucleotides. This specific sequence affinity 
increases in several cases: lengthening of single-stranded oligonu- 
cleotides, formation of stable duplexes between complementary 
oligonucleotides and preincubation of the enzyme with ligands 
before addition of supercoiled DNA. We assume that oligonucle- 
otides having a high affinity to the enzyme can offer a unique 
opportunity for rational design of topoisomerase-targeting drugs. 
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Since cleavage in DNA occurs only at sites situated in regions 
with the potential for intrastrand base-pairing due to distal 
complementary sequences [20], topo I has been considered to 
be a ds-specific enzyme. In fact in the literature there are no 
data as to whether topo I is capable of binding to short ss 
ODNs. Furthermore, it is a general belief that ds DNA-depend- 
ent enzymes cannot interact with short ss ODNs (for review see 
[21]). We have shown previously that this is not true using 
various kinds of DNA polymerases and repair enzymes [21]. 
Thus it is relevant and of great interest to examine whether topo 
I binds with any affinity to short ss ODNs with specific se- 
quences. 
We therefore investigated the possibility of complex forma- 
tion of topo I with ss and ds short ODNs of specific and 
non-specific sequences. The results demonstrated that both spe- 
cific and non-specific ODNs have a high affinity to the enzyme 
and they are effective inhibitors of topo I-dependent relaxation 
of supercoiled DNA. 
1. Introduction 2. Materials and methods 
DNA topoisomerases are enzymes that change the topologi- 
cal state of DNA by transient breakage and rejoining of the 
sugar-phosphate backbone [1 5]. Topos have been shown to 
be involved in various biological processes uch as DNA repli- 
cation, transcription, recombination and chromosome dynam- 
ics [1-9], and are the pharmacological targets of a number of 
antitumor drugs [10--12]. This holds for topo I [13 17] and thus 
a better understanding of the molecular mechanisms of func- 
tioning of this enzyme is important from fundamental and 
applied points of view. 
Topo I is a sequence-dependent zyme. It protects both 
strands of the binding sequence over a 20-bp region in which 
the cleavage site is centrally located [18]. Minimal DNA duplex 
requirements for DNA cleavage in the recognition sequence 
have been delimited to nine nucleotides on the scissile strand 
and five nucleotides on the non-cleaved strand as illustrated 
below [19]: 
p¢)int of c leavage 
5 ' -TAA AAGACTT~AG AAAAATT-3 '  
3 ' -ATT  TTCTGAA TC-TTT  TT AA-5'  
Sc colEl DNA was purchased from Wakojunyaku Co. Ltd. (Japan). 
All ODNs were synthesized as in [22]. Concentrations of ODNs were 
determined according to [23]. Topo I was obtained from mouse Ehrlich 
ascites tumor cells as before [24]. 
Topo I activity was measured by assessing relaxation of sc colEl 
DNA at 30°C. The reaction mixture (20¢tl) contained: 50 mM Tris-HC1 
(pH 8.0), 70 ¢tg/ml BSA, 0.5 mM DTT, 0.5 mM EDTA, 15% glycerol, 
130 mM NaCI, 10 ¢tg/ml colEl sc DNA and 1 unit of topo I. ODNs 
were used at different concentrations. 
Samples were incubated for 15 min and the results for ODN inhibi- 
tion of topo I-dependent relaxation of sc DNA were estimated with two 
methods: (a) agarose gel electrophoresis a in [24] and the pH 12 ethid- 
ium fluorescence assay according to [25]. Preincubation f topo I with 
ODNs was done using standard conditions without DNA for 15 min 
at 23°C. The relaxation reaction was started by addition of colE1 DNA 
and the mixture was further incubated for 15 rain at 30°C. Analysis of 
the reaction mixtures was performed using two methods as described 
above. 
32p-labeled at the 5'-end (using T4 polynucleotide kinase and ),- 
[32p]ATP) ss ODNs and their duplexes were analyzed for covalent 
suicidal binding with the enzyme analogously to [19]. 
The K, values for ODNs were estimated from fluorescence assay 
using dependencies IlV versus I/S according to [26]. 
3. Results and discussion 
*Corresponding author. 
Abbreviations: IC50, the concentration giving 50% inhibition of the 
activity; topo, DNA topoisomerase; ODN, oligodeoxynucleotide; ss 
and ds, single- and double-stranded, respectively; scDNA, supercoiled 
DNA. 
We examined whether topo I, like some other ds DNA- 
dependent enzymes, is capable of binding different short ss and 
ds ODNs. The ODNs containing cleaved strand sequences (cor- 
responding to duplex region required for topo I-mediated 
cleavage, see section 1) were marked as C-ODNs and those 
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Table 1 
Concentrations of oligonucleotides inhibiting the DNA relaxation ac- 
tivity of DNA topoisomerase I by 50% (ICs0) 
Oligos ICs0 (1) ICs0 (2) Ratio 
and their - preincubation + preincubation ICs0 (1)/ 
mixtures (mM) (mM) IC5o (2) 
d(pT)5 15,600 5,200 3 
d(pA)5 12,600 4,200 3 
d(pT)5 + d(pA)5 2,100 700 3 
NC5 110 10 11 
C5 2.0 0.4 5 
NC9 2.5 0.2 12.5 
C9 2.0 0.4 5 
C5 + NC5 9.0 1.2 7.5 
C9 + NC5 0.8 0.2 4.0 
C5 + NC9 35.0 2.0 17.5 
C9 + N9 0.8 0.1 8.0 
NC27 + C27 0.07 0.01 7.0 
All ODNs and their mixtures were heated for 5 min at 95°C and were 
slowly cooled to 20°C, and then were assayed for their inhibition of 
topo I relaxation activity. Sequences of oligonucleotides used (5'-3'): 
C5, GACTT; C9, AAGACTTAG; C27, AAAAAGACTTAGAAAA- 
ATTTTTAAAG; NC5, AAGTC; NC9, CTAAGTCTT; NC27, CTT- 
TAAAAATTTTTCTAAGTCTTTTTT. Standard errors did not ex- 
ceed 20M0%. 
containing non-cleaved strand sequences as NC-ODNs (see 
Table 1). Results for ODN inhibition of topo I-dependent re- 
laxation of sc DNA were obtained with two methods; standard 
agarose gel electrophoresis and the pH 12 ethidium fluores- 
cence assay coincided very well, as illustrated in Fig. 1 using 
NC5 as an example. Only the ethidium fluorescence assay al- 
lows an accurate quantitation of the enzyme inhibition. Inter- 
ference by ODNs with the ethidium fluorescence measurement 
was not observed. Therefore the latter method was applied for 
estimation of the relative amounts of relaxed and sc colE1 
DNA in the reaction mixtures in the absence and in the pres- 
ence of ODNs. 
All ss- and ds-specific and non-specific ODNs were found to 
inhibit topo I. Fig. 2 demonstrates that C9 is a competitive 
inhibitor (Ki --- 1.5 + 0,6pM) towards c DNA. The same result 
was obtained for C9 × NC9 and d(pT)5 (K~ = 0.5 + 0.2pM and 
10 + 4 raM, respectively). The above Ki values are comparable 
with ICs0 values estimated for ODNs (Table 1). For all other 
ODNs ICs0 values were analyzed and are summarized inTable 
1. 
Preincubation f topo I at 23°C without ligands for 1 h did 
not change its activity. As shown in Fig. 3, addition of 30 or 
100 pM NC5 to the reaction mixture resulted in 30% and 50% 
inhibition, respectively, (no preincubation), when preincuba- 
tion of topo I with the NC5 for 10 rain (effect completed within 
10 min) caused a pronounced increase in inhibition up to 60% 
and 90%, respectively. Similar results were revealed for all ss 
and ds ODNs (Table 1). 
Incubation of topo I with sc DNA leads usually to the 'sui- 
cide covalent complex' formation [27,28]. We preincubated 
topo I with 5'-[32p]-labeled ss ODNs C27, C9, d(pT)5 and ds 
ODNs C27 x NC27, C9 × NC9, d(pT)5 xd(pA)5 for 15 rain at 
23°C. No detectable covalent binding of the label with the 
protein was observed by polyacrylamide g l electrophoresis. 
Thus increase of the inhibition level after topo I preincubation 
with ODNs is not due to covalent attachment of ODNs to the 
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enzyme but rather to reversible interaction and probably tran- 
sition of ODNs to optimal conformation. 
As one can see from Table 1, the enzyme affinity for specific 
ODNs (GACTT and AAGTC) is about 2~, orders of magni- 
tude higher than that for non-specific d(pT)5 or d(pA)5. This 
specific sequence affinity increases in several cases: lengthening 
of ss ODNs, formation of stable duplexes between complemen- 
tary ODNs and preincubation f the enzyme with ligands be- 
fore addition of sc DNA. 
As the melting point of the C27 x NC27 complex should be 
significantly higher than the reaction temperature (30°C) 
[29,30], it is not surprising that the C27 × NC27 duplex demon- 
strated the highest affinity to the enzyme. The melting point of 
ODNs with complementary penta- and nonanucleotides are 
lower than 7 8°C and 25°C, respectively [27,28]. In spite of 
this, mixtures of C9 + NC5 or C9 + NC9 gave ICs0 values 
which are at least 4~20 times lower than those of corresponding 
ss NC5, C9 or NC9 (Table 1). Thus after initial recognition of 
ss ODNs, which cannot form duplexes by themselves at30 ° C, 
the enzyme combines and stabilizes them as duplexes. 
The present findings (Table 1) speak in favor of a different 
contribution to the affinity of two chains of complementary 
duplexes. The contribution to the affinity of two chains of 
complementary oligonucleotides is far from being simply addi- 
tive (Table 1). It seems most likely that one chain of the duplex 
forms a strong specific contact with the enzyme and the other 
chain a significantly weaker one. 
A 
1 2 3 4 5 6 7 8 9 1011121314151617 
B 100 2 
0 | i | , i J , I = I i i i i i , , , i i 
0 1 2 
[3 ' -CTGAA-5' ]x l0  -4, M 
Fig. 1. Comparison of NC5 inhibition of topo I relaxation activity by 
agarose gel electrophoresis (A)and by ethidium fluorescence assay (B) 
before (A, lanes 3-9; B, 1) and after preincubation f the enzyme with 
NC5 (A, lanes 10-16; B, 2). The concentrations of NC5 used: 1 (lanes 
3,10), 2 (lanes 4,11) 5 (lanes 5,12), 10 (lanes 6,13), 20 (lanes 7,14), 100 
(lanes 8,15) and 200 aM (lanes 9,16). Standard reaction mixtures incu- 
bated without opo I (lanes 1,17) or without NC5 0ane 2) were used 
as controls. 
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Fig. 2. Inhibition of the relaxation catalyzed by topo I was measured at various concentrations of supercoiled DNA substrate (S) in the presence 
of C9 at different concentrations: 1.0 (1), 2.0 (2) and 3.0 #M (3), respectively. 
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We have shown here, for the first time, that topo I can 
interact with high affinity even for short ODNs of specific 
sequence. The natural substrate of topo I is sc DNA having 
torsional stress, and the lack of this stress prevents, or at least 
markedly decreases, the efficiency of substrate topcisomeriza- 
tion [30,31]. Therefore the highest affinity observed for the 
C27 x NC27 complex was still about 2-3 orders of magnitude 
lower than that for sc DNA (Kin = 0.1 nM). At the same time, 
affinity of some short specific ODNs is higher than that of most 
known specific inhibitors of topo I, e.g. the ICs0 value for 
camptothecin (ICs0 = 30/,tM) [14,16]. Thus specific oligonucle- 
otides offer a unique opportunity for rational design of topoi- 
somerase-targeting drugs. 
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Fig. 3. Effect of preincubation of topo I with oligonucleotides, Topo 
I was incubated at 23~C in the absence (1) or in the presence of NC5: 
30 (2) or 100 #M (3) in the standard reaction mixture without sc DNA. 
Aliquots of the mixture (16/.4) were drawn at intervals of 1-20 rain and 
the relaxation reaction was started by addition of 4 #ml solution of sc 
DNA, followed by additional incubation for 15 min at 30°C. The 
difference between topo I activity in the absence and in the presence of 
the NC5 at zero time incubation was taken as the enzyme inhibition by 
NC5 without preincubation. 
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